申请人:Bayer Aktiengesellschaft
公开号:US05571921A1
公开(公告)日:1996-11-05
The present invention relates to substituted (2-oxo-1-benzimidazolinyl)-piperidines of the general formula (I) ##STR1## in which the substituents have the meaning indicated in the description, to processes for their preparation and to their use as antiretroviral agents.
本发明涉及一般式(I)的取代(2-氧代-1-苯并咪唑啉基)-哌啶衍生物,其中取代基的含义如描述中所示,以及它们的制备方法和作为抗逆转录病毒药物的用途。